Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-08 | New | $22,000,000 | $22,000,000 | Equity Only | 06b | SEC link |
| 2024-12-30 | New | $999,984 | $999,984 | Equity Only | 06b | SEC link |
| 2023-06-22 | New | $17,855,020 | $17,855,020 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Manuel Aguero | Director |
| Brian Cox | Executive |
| Bryan F. Cox | Executive |
| Arjun Desai | Director |
| Jodi Devlin | Executive |
| Christopher C. Dewey | Director, Executive |
| Gary Gordon | Director |
| Kerry Hicks | Director |
| Liselotte Hyveled | Director |
| Karim Karti | Director |
| Richard Marshak | Executive |
| George Kelly Martin | Director |
| David J. Matlin | Director |
| Sean Murphy | Director |
| Martin Roche | Director |
| Jennifer Stevens | Executive |
| Mary Szela | Director, Executive |
| Thierry Thaure | Director |
| David L. Treadwell | Director |
| William F. Valle | Director |
| Andrew Von Eschenbach | Director |
| Mats Wahlstrom | Director |
| Robert H. Weiss | Executive |
| James Young | Executive |